Prosonix is an innovative speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by design
Oct 7, 2013
Generics Bulletin profiles the exciting potential of Prosonix' respiratory pipeline and...
Aug 16, 2013
Final Patient Completes Prosonix’ Phase 2 Clinical Study with PSX1002 in Moderate to Severe...
Jul 1, 2013
Prosonix Appoints Frank Condella as Non-executive Director
20-21 Nov 2013
11-13 Dec 2013